CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Leerink Upgrades Zentalis Pharmaceuticals to Outperform From Market Perform, Price Target is $8

Positive
AI Analysis

Summary

Leerink upgraded Zentalis Pharmaceuticals to Outperform from Market Perform with a price target of $8.

Outcome Details

Analyst upgrade to Outperform from Market Perform with $8 price target

Importance:4/10
Sentiment:
0.60
analyst upgradeprice target
Related Companies

Read the original article

Published by yahoo_finance on October 5, 2026 11:08 AM

Read Original